184 related articles for article (PubMed ID: 12380903)
1. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
Ren Fail; 2002 Sep; 24(5):585-93. PubMed ID: 12380903
[TBL] [Abstract][Full Text] [Related]
2. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
Ren Fail; 2002 Jul; 24(4):467-75. PubMed ID: 12212826
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide synthase affects the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Tesar V; Stekrová J
Kidney Blood Press Res; 2002; 25(2):87-90. PubMed ID: 12077489
[TBL] [Abstract][Full Text] [Related]
4. The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Miroslav M; Stekrová J; Kohoutová M; Tesar V; Kmentová D; Hubácek JA; Viklický O
Ren Fail; 2004 Mar; 26(2):119-25. PubMed ID: 15287194
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal diseases.
Wang Y; Kikuchi S; Suzuki H; Nagase S; Koyama A
Nephrol Dial Transplant; 1999 Dec; 14(12):2898-902. PubMed ID: 10570094
[TBL] [Abstract][Full Text] [Related]
6. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
[TBL] [Abstract][Full Text] [Related]
7. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease.
Asakimori Y; Yorioka N; Yamamoto I; Okumoto S; Doi S; Hirai T; Taniguchi Y
Nephron; 2001 Oct; 89(2):219-23. PubMed ID: 11549906
[TBL] [Abstract][Full Text] [Related]
8. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus.
Lamnissou K; Zirogiannis P; Trygonis S; Demetriou K; Pierides A; Koptides M; Deltas CC
Genet Test; 2004; 8(3):319-24. PubMed ID: 15727257
[TBL] [Abstract][Full Text] [Related]
9. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
10. Effect of a polymorphism of endothelial nitric oxide synthase gene in Japanese patients with IgA nephropathy.
Morita T; Ito H; Suehiro T; Tahara K; Matsumori A; Chikazawa H; Nakauchi Y; Nishiya K; Hashimoto K
Clin Nephrol; 1999 Oct; 52(4):203-9. PubMed ID: 10543322
[TBL] [Abstract][Full Text] [Related]
11. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O
Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315
[TBL] [Abstract][Full Text] [Related]
12. G protein beta3 subunit C825T polymorphism in primary IgA nephropathy.
Thibaudin L; Berthoux P; Thibaudin D; Mariat C; Berthoux F
Kidney Int; 2004 Jul; 66(1):322-8. PubMed ID: 15200440
[TBL] [Abstract][Full Text] [Related]
13. The influence of endothelin-A receptor gene polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Reiterová J; Merta M; Stekrová J; Maixnerová D; Obeidová H; Kebrdlová V; Viklický O; Tesar V
Folia Biol (Praha); 2007; 53(4):134-7. PubMed ID: 17706018
[TBL] [Abstract][Full Text] [Related]
14. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
Walker D; Consugar M; Slezak J; Rossetti S; Torres VE; Winearls CG; Harris PC
Am J Kidney Dis; 2003 Jan; 41(1):90-4. PubMed ID: 12500225
[TBL] [Abstract][Full Text] [Related]
15. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
[TBL] [Abstract][Full Text] [Related]
16. CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: the 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis.
Berthoux FC; Berthoux P; Mariat C; Thibaudin L; Afiani A; Linossier MT
Kidney Int; 2006 Feb; 69(3):565-72. PubMed ID: 16395252
[TBL] [Abstract][Full Text] [Related]
17. Systemic redox biomarkers and their relationship to prognostic risk markers in autosomal dominant polycystic kidney disease and IgA nephropathy.
Tariq A; Mansoor MA; Marti HP; Jonsson G; Slettan A; Weeraman P; Apeland T
Clin Biochem; 2018 Jun; 56():33-40. PubMed ID: 29655960
[TBL] [Abstract][Full Text] [Related]
18. Modifier effect of ENOS in autosomal dominant polycystic kidney disease.
Persu A; Stoenoiu MS; Messiaen T; Davila S; Robino C; El-Khattabi O; Mourad M; Horie S; Feron O; Balligand JL; Wattiez R; Pirson Y; Chauveau D; Lens XM; Devuyst O
Hum Mol Genet; 2002 Feb; 11(3):229-41. PubMed ID: 11823442
[TBL] [Abstract][Full Text] [Related]
19. Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease.
Xue C; Zhou CC; Sun LJ; He LL; Xu CG; Dai B; Mei CL
Nephrology (Carlton); 2014 Oct; 19(10):630-7. PubMed ID: 24995932
[TBL] [Abstract][Full Text] [Related]
20. [Progression of autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms].
Azurmendi P; Fraga A; Muchnik C; Dos Ramos Farias M; Galan F; Guerra D; O'Flaherty M; Arrizurieta E; Martin R
Medicina (B Aires); 2004; 64(2):139-42. PubMed ID: 15628301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
